Methods for parallel detection of compositions having desired characteristics
OwnerSergey A. Selifonov, Gjalt W. Huismaninventors
Life of this patent
Estimating the term…
Abstract
Methods and apparatuses for performing high throughput magnetic resonance imaging spectroscopy, e.g., to screen libraries of chemical or biological compositions for a compound of interest, are provided. Methods of identifying metabolic disorder genes, modulatory compounds and catalysts, and methods of optimizing reaction conditions, using high throughout MRI screening, are also provided.
Claims115
A method of screening a plurality of samples for a selected property, the method comprising:
- (i) providing an artificially generated physical array, which physical array comprises one or more samples at each of a plurality of spatial locations;
- (ii) placing the physical array in a magnetic field or applying a magnetic field to the physical array;
- (iii) performing magnetic resonance imaging spectroscopy (MRI) on the one or more samples of the physical array, thereby identifying the spatial location for each of the one or more samples having one or more MRI detectable chemical shifts, which one or more chemical shifts correspond to the selected property, thereby screening the plurality of samples for the selected property.
An apparatus for screening a plurality of samples, the apparatus comprising:
- (i) a magnetic resonance imaging spectrometer;
- and,
- (ii) at least one microwell plate or other artificially generated physical array, wherein during operation of the apparatus the at least one microwell plate or other artificially generated physical array is positioned within a magnetic field produced by the magnetic resonance imaging spectrometer.
A method of identifying metabolic disorder genes, the method comprising:
- (i) providing a plurality of cells, which cells comprise a library of mutated cells or have been transformed with a plasmid containing one or more members of a library of gene sequences, which cells produce one or more metabolites;
- (ii) performing magnetic resonance imaging (MRI) spectroscopy on the plurality of cells or on the one or more metabolites, thereby detecting the one or more metabolites;
- (iii) identifying one or more cells that produce a reduced or increased level of at least one of the one or more metabolites, as compared to a standard, thereby identifying one or more metabolic disorder genes.
A method of identifying a modulatory compound, the method comprising:
- (i) providing a plurality of cells, which cells comprises a library of mutated cells or have been transformed with a plasmid containing one or more members of a library of gene sequences, which cells produce one or more metabolites;
- (ii) performing magnetic resonance (MRI) spectroscopy on the plurality of cells or on the one or more metabolites, thereby detecting the one or more metabolites;
- (iii) identifying one or more cells that produce a reduced or increased level of at least one of the one or more metabolites, as compared to a standard;
- (iv) screening a plurality of potential modulatory compounds by MRI spectroscopy for alleviation of the reduced or increased level of the at least one of the one or more metabolites;
- (v) identifying one or more of the plurality of potential modulatory compounds that alleviate the reduced or increased level of the at least one of the one or more metabolites, thereby identifying a modulatory compound.
A method of identifying a catalyst, the method comprising:
- (i) providing a plurality of assay solutions, which plurality of assay solutions comprises at least one reactant;
- (ii) providing a plurality of catalysts;
- (iii) combining the plurality of assay solutions and the plurality of catalysts;
- (iv) performing magnetic resonance (MRI) spectroscopy on the plurality of assay solutions, thereby detecting one or more products generated by an action of one or more members of the plurality of catalysts on the at least one reactant;
- and
- (v) identifying one or more members of the plurality of catalysts that alter the level of the at least one of the one or more products, thereby identifying a catalyst.
A method of optimizing a reaction condition for a catalyst, the method comprising:
- (i) providing a plurality of assay solutions, which plurality of assay solutions comprises a reactant and a catalyst;
- (ii) exposing the plurality of assay solutions to one or more of a plurality of reaction conditions;
- (iii) performing magnetic resonance (MRI) spectroscopy on the plurality of assay solutions, thereby detecting one or more products generated by an action of the catalyst on the reactant;
- (iv) identifying one or more of the plurality of reaction conditions that alter the level of at least one of the one or more products;
- and
- (v) analyzing the one or more of the plurality of reaction conditions, thereby optimizing the reaction condition for the catalyst.
Dependencies are inferred from the claim text.